GC18728
CJ-13610
Also known as 4-[3-[4-(2-methylimidazol-1-yl)phenyl]sulfanylphenyl]oxane-4-carboxamide
CJ-13610 is an inhibitor of 5-lipoxygenase (5-LO) that inhibits 5-LO product formation in human polymorphonuclear leukocytes (PMNLs) challenged with A23187 in vitro (IC50 = 70 nM)
ChemicalCAS179420-17-8MW393.5FormulaC22H23N3O2S
- CAS number
- 179420-17-8
- Molecular weight
- 393.5
- Formula
- C22H23N3O2S
- Solubility
- DMSO： 10 mg/ml,Ethanol： 1 mg/ml
- InChIKey
- VPTONMHDLLMOOV-UHFFFAOYSA-N
- Catalogue number
- GC18728
- Brand
- GLPBIO
Computed properties PubChem CID 9821945 · XLogP 3.2 · TPSA 95.4 Ų · H-bond donors 1
- XLogP
- 3.2
- TPSA
- 95.4 Ų
- H-bond donors
- 1
- H-bond acceptors
- 4
- Rotatable bonds
- 5
- Heavy atoms
- 28
SMILES CC1=NC=CN1C2=CC=C(C=C2)SC3=CC=CC(=C3)C4(CCOCC4)C(=O)N
Computed descriptors from PubChem (CID 9821945), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il